Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia

被引：2
|
作者：
Singh, Aniruddha [1 ]
Mittal, Shilpi [2 ]
Kazimuddin, Mohammed [1 ]
机构：
[1] Med Ctr, Bowling Green, KY USA
[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2021年 / 384卷 / 01期
关键词：
D O I：
10.1056/NEJMc2032399
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：84 / 84
页数：1
相关论文
共 50 条
  • [41] DIET IN CHILDREN HETEROZYGOUS FOR FAMILIAL HYPERCHOLESTEROLEMIA
    GLUECK, CJ
    TSANG, RC
    FALLAT, RW
    MELLIES, MJ
    [J]. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1977, 131 (02): : 162 - 166
  • [42] Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia
    Raal, Frederick J.
    Kallend, David
    Ray, Kausik K.
    Turner, Traci
    Koenig, Wolfgang
    Wright, R. Scott
    Wijngaard, Peter L. J.
    Curcio, Danielle
    Jaros, Mark J.
    Leiter, Lawrence A.
    Kastelein, John J. P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (16): : 1520 - 1530
  • [43] PROCEDURE FOR THE DIAGNOSIS OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Benedi, Victoria Marco
    Gasso, Salvador Olmos
    Lagunas, Ana Cenarro
    Corredoira, Pablo Fernandez
    Sanz, Ana M. Bea
    Murillo, Fernando Civeira
    [J]. ATHEROSCLEROSIS, 2024, 395
  • [44] LONG-TERM EVOLOCUMAB USE IN SUBJECTS WITH HOMOZYGOUS AND SEVERE HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: PRIMARY RESULTS OF THE TAUSSIG TRIAL
    Santos, Raul
    Hovingh, G. Kees
    Blom, Dirk
    Soran, Handrean
    Watts, Gerald
    Lopez, J. Antonio
    Bray, Sarah
    Kurtz, Christopher
    Hamer, Andrew
    Raal, Frederick
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1715 - 1715
  • [45] Is Deprescription of Ezetimibe Safe in Familial Hypercholesterolemia Patients Taking Evolocumab?
    Hang, Shyann
    Lazarte, Julieta
    Hegele, Robert A.
    [J]. CJC OPEN, 2022, 4 (04) : 428 - 431
  • [46] EFFECT OF EVOLOCUMAB ON COGNITION IN PEDIATRIC PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA: RESULTS FROM THE HAUSER-RCT STUDY
    Gaudet, D.
    Ruzza, A.
    Bridges, I.
    Maruff, P.
    Schembri, A.
    Hamer, A.
    Kurtz, C. E.
    Mach, F.
    Bergeron, J.
    Gaudet, I.
    St-Pierre, J.
    Kastelein, J. J. P.
    Hovingh, G. K.
    Wiegman, A.
    Raal, F. J.
    Santos, R.
    [J]. ATHEROSCLEROSIS, 2021, 331 : E258 - E258
  • [47] COST-EFFECTIVENESS OF EVOLOCUMAB IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN BELGIUM
    Descamps, O. S.
    Van Hout, B.
    Lindgren, P.
    Villa, G.
    Urbich, M.
    Fonarow, G. C.
    [J]. ATHEROSCLEROSIS, 2020, 315 : E36 - E36
  • [48] COST-EFFECTIVENESS ANALYSIS OF UNIVERSAL SCREENING PEDIATRIC FOR HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN ARGENTINA
    Araujo, M. B.
    [J]. ATHEROSCLEROSIS, 2020, 315 : E192 - E192
  • [49] DIFFERENT PHENOTYPES IN SIBLINGS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Kyselak, O.
    Soska, V.
    [J]. ATHEROSCLEROSIS, 2018, 275 : E182 - E182
  • [50] Mortality from heterozygous familial hypercholesterolemia.
    Sijbrands, EJG
    Defesche, JC
    Lombardi, P
    Westendorp, RJG
    Smelt, AHM
    Kastelein, JJP
    [J]. CIRCULATION, 1996, 94 (08) : 4321 - 4321
12345